Announced
Completed
Synopsis
Neuraxpharm, a central nervous system specialist, completed the acquisition of two product portfolios of Sanofi, a pharmaceutical and healthcare company. Financial terms were not disclosed. "These newly acquired products not only strengthen our presence as a leading European specialty pharmaceutical company focused on CNS, but also lay the ground for further expansion of our international presence," Jörg Thomas Dierks, Neuraxpharm CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.